Akira Matsuno

Co-Founder, President, COO & CFO @ Tune Therapeutics

Country

United States

City

Seattle

Industry

Biotechnology

Skill

Private Equity, LBO, Mergers, Deal Sourcing, Principal Investing, Corporate Development, Acquisitions, Financial Sponsors, Deal Execution, Negotiation, Transaction Sourcing, Strategic M&A, Distressed M&A, M&A analysis, Valuation, Investment Valuation, Due Diligence, Business Strategy, Strategic Partnerships, Growth Capital

Experience

Co-Founder, President, COO & CFO

Tune Therapeutics

2020-1 - Present · 6 yrs 9 mos

Member of the Board of Advisors

Fred Hutch

2025-5 - Present · 1 yr 5 mos

Board Member

Life Science Washington

2023-12 - Present · 2 yrs 10 mos

CFO & Head of Corporate Development

Lyell Immunopharma

2018 - 2019 · 1 yr

Greater Seattle Area

VP, NEX-T Platform Program Lead

Juno Therapeutics, Inc.

2017 - 2018 · 1 yr

VP Finance

Juno Therapeutics, Inc.

2013 - 2018 · 5 yrs

Greater Seattle Area

Juno Therapeutics is a clinical-stage cellular immunotherapy company developing therapies that harness the immune system of cancer patients to treat a broad range of cancers

Principal

Stoneledge Partners

2013 - 2013

Deep expertise in all sectors of the media, mobile, communications and technology industry. Four primary services: strategic & operating advisory; business development support; business & financial plan review; and capital raising support.

Director, Corporate Development

Motricity

2009 - 2013 · 4 yrs

Publicly traded company with ~$100 MM in revenue providing mobile merchandising, mobile marketing and mobile advertising solutions to wireless carriers, enterprises and agencies.